Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: Leukemia. 2014 Feb 3;28(7):1543–1545. doi: 10.1038/leu.2014.54

Table 1a. Patient characteristics.

Patient Characteristics N %
Patients Treated 62 100
Median age (range) in years 53 (18-66)
Patients ≥ 60 years 12 19
Median WBC×109/L (range) 7.25 (0.6-228.5)
Cytogenetics
 Adverse risk 10 16
 Intermediate risk 48 77
 Favorable risk 1 2
 Insufficient Metaphases 3 5
FLT3 mutation status
 Wild type 39 63
 Mutated 23 37
   ITD 17 27
   D835 4 6
   Both 2 3
FLT3 -ITD allele burden
 High >25% 8 42
 Low ≤25% 11 58